Literature DB >> 20646779

Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinoma.

Kyoichi Kaira1, Masahiro Endo, Masato Abe, Kazuo Nakagawa, Yasuhisa Ohde, Takehiro Okumura, Toshiaki Takahashi, Haruyasu Murakami, Asuka Tsuya, Yukiko Nakamura, Tateaki Naito, Isamu Hayashi, Haruhiko Kondo, Takashi Nakajima, Nobuyuki Yamamoto.   

Abstract

BACKGROUND: Pulmonary pleomorphic carcinoma is a rare epithelial tumor, and little is also known about the information on the usefulness of 2-[¹⁸F]-fluoro-2-deoxy-d-glucose (¹⁸F-FDG) positron emission tomography (PET). Therefore, we conducted the study including the underlying biologic analysis of ¹⁸F-FDG uptake.
METHODS: Fifteen patients with pulmonary pleomorphic carcinoma who underwent ¹⁸F-FDG PET before treatment were included in this study. Tumor sections were stained by immunohistochemistry for glucose transporter 1 (Glut1); glucose transporter 3 (Glut3); hypoxia-inducible factor-1 alpha (HIF-1α); cell proliferation (Ki-67 labeling index); vascular endothelial growth factor (VEGF); microvessels (CD34); cell cycle control marker (p53); and apoptosis marker (bcl-2). These parameters were correlated with a control group of patients with other non-small cell lung cancer (NSCLC) (n=33).
RESULTS: The maximal standardized uptake value (SUV(max)) of the primary tumors in 15 patients ranged from 6.1 to 26.8 (median 19.3). There were positive correlation between ¹⁸F-FDG uptake and Glut1 (p=0.0016), Glut3 (p=0.0080), VEGF (p=0.0048), and microvessel density (MVD) (p=0.0005). HIF-1α, p53 and bcl-2 showed no positive correlation with ¹⁸F-FDG uptake. ¹⁸F-FDG uptake, Glut1, Glut3, HIF-1α, VEGF and Ki-67 were significantly higher in patients with pulmonary pleomorphic carcinoma than those with other NSCLC.
CONCLUSION: ¹⁸F-FDG uptake in pulmonary pleomorphic carcinoma is closely associated with the presence of glucose metabolism (Glut1 and Glut3) and angiogenesis (VEGF and MVD). The relationship between ¹⁸F-FDG uptake and these biomarkers may lead to a more rational use of PET scan in pulmonary pleomorphic carcinoma. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20646779     DOI: 10.1016/j.lungcan.2010.05.021

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  13 in total

1.  Clinicopathological factors influenced the prognosis of surgically resected pulmonary pleomorphic carcinoma.

Authors:  Katsuhiro Okuda; Risa Oda; Ayumi Suzuki; Tadashi Sakane; Osamu Kawano; Hiroshi Haneda; Satoru Moriyama; Ryoichi Nakanishi
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis.

Authors:  Yumin Hu; Weiqin Lu; Gang Chen; Peng Wang; Zhao Chen; Yan Zhou; Marcia Ogasawara; Dunyaporn Trachootham; Li Feng; Helene Pelicano; Paul J Chiao; Michael J Keating; Guillermo Garcia-Manero; Peng Huang
Journal:  Cell Res       Date:  2011-08-30       Impact factor: 25.617

3.  A systemic review of PET and biology in lung cancer.

Authors:  Kyoichi Kaira; Noboru Oriuchi; Noriaki Sunaga; Tamotsu Ishizuka; Kimihiro Shimizu; Nobuyuki Yamamoto
Journal:  Am J Transl Res       Date:  2011-07-27       Impact factor: 4.060

4.  Assessment of the metabolic flow phenotype of primary colorectal cancer: correlations with microvessel density are influenced by the histological scoring method.

Authors:  Vicky Goh; Manuel Rodriguez-Justo; Alec Engledow; Manu Shastry; Raymondo Endozo; Jacqui Peck; Marie Meagher; Stuart A Taylor; Steve Halligan; Ashley M Groves
Journal:  Eur Radiol       Date:  2012-04-18       Impact factor: 5.315

5.  Hyperpolarized [1-13C]dehydroascorbate MR spectroscopy in a murine model of prostate cancer: comparison with 18F-FDG PET.

Authors:  Kayvan R Keshari; Victor Sai; Zhen J Wang; Henry F Vanbrocklin; John Kurhanewicz; David M Wilson
Journal:  J Nucl Med       Date:  2013-04-10       Impact factor: 10.057

6.  Standardized Uptake Values Derived from 18F-FDG PET May Predict Lung Cancer Microvessel Density and Expression of KI 67, VEGF, and HIF-1α but Not Expression of Cyclin D1, PCNA, EGFR, PD L1, and p53.

Authors:  Alexey Surov; Hans Jonas Meyer; Andreas Wienke
Journal:  Contrast Media Mol Imaging       Date:  2018-06-06       Impact factor: 3.161

7.  CAV1 - GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung Cancer.

Authors:  Azhar Ali; Elena Levantini; Chee Wai Fhu; Jun Ting Teo; John G Clohessy; Julian L Goggi; Chan-Shuo Wu; Leilei Chen; Tan Min Chin; Daniel G Tenen
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

8.  Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma.

Authors:  Hisao Imai; Kyoichi Kaira; Hideki Endoh; Kazuyoshi Imaizumi; Yasuhiro Goto; Mitsuhiro Kamiyoshihara; Takayuki Kosaka; Toshiki Yajima; Yoichi Ohtaki; Takashi Osaki; Yoshihito Kogure; Shigebumi Tanaka; Atsushi Fujita; Tetsunari Oyama; Koichi Minato; Takayuki Asao; Ken Shirabe
Journal:  J Clin Med       Date:  2020-02-03       Impact factor: 4.241

9.  Selective growth inhibition by glycogen synthase kinase-3 inhibitors in tumorigenic HeLa hybrid cells is mediated through NF-κB-dependent GLUT3 expression.

Authors:  M Watanabe; N Abe; Y Oshikiri; E J Stanbridge; T Kitagawa
Journal:  Oncogenesis       Date:  2012-07-09       Impact factor: 7.485

10.  Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases.

Authors:  Si-Yuan Huang; Shu-Jing Shen; Xing-Ya Li
Journal:  World J Surg Oncol       Date:  2013-10-02       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.